Article:
Chordoma: Protein Expression (Part II)
- The expression of Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase and alpha 2,6-linked sialoglycoconjugates in human brain tumors. Kaneko, Y., Yamamoto, H., Kersey, D.S., Colley, K.J., Leestma, J.E., Moskal, J.R. Acta Neuropathol. (1996)
- Immunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM) in chordoma. Naka, T., Oda, Y., Iwamoto, Y., Shinohara, N., Chuman, H., Fukui, M., Tsuneyoshi, M. J. Clin. Pathol. (2001)
- Cadherins and catenins in clival chordomas: correlation of expression with tumor aggressiveness. Triana, A., Sen, C., Wolfe, D., Hazan, R. Am. J. Surg. Pathol. (2005)
- Expression of E-cadherin in chordomas: diagnostic marker and possible role of tumor cell affinity. Mori, K., Chano, T., Kushima, R., Hukuda, S., Okabe, H. Virchows. Arch. (2002)
- Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Oakley, G.J., Fuhrer, K., Seethala, R.R. Mod. Pathol. (2008)
- Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma. Naka, T., Kuester, D., Boltze, C., Schulz, T.O., Samii, A., Herold, C., Ostertag, H., Roessner, A. Hum. Pathol. (2008)
- Expression of cell adhesion molecules in chordomas: an immunohistochemical study of 16 cases. Horiguchi, H., Sano, T., Qian, Z.R., Hirokawa, M., Kagawa, N., Yamaguchi, T., Hirose, T., Nagahiro, S. Acta. Neuropathol. (2004)
- Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications. Mitchell, A., Scheithauer, B.W., Unni, K.K., Forsyth, P.J., Wold, L.E., McGivney, D.J. Cancer. (1993)
- Chordomas of the mediastinum: clinicopathologic, immunohistochemical, and ultrastructural study of six cases presenting as posterior mediastinal masses. Suster, S., Moran, C.A. Hum. Pathol. (1995)
- Immunoperoxidase staining for carcinoembryonic antigen in colonic carcinoma, osteosarcoma, and chordoma. Harrowe, D.J., Taylor, C.R. J. Surg. Oncol. (1981)
- Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas. Orzan, F., Terreni, M.R., Longoni, M., Boari, N., Mortini, P., Doglioni, C., Riva, P. Oncol. Rep. (2007)
- Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development. Gottschalk, D., Fehn, M., Patt, S., Saeger, W., Kirchner, T., Aigner, T. Am. J. Pathol. (2001)
- Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma. Chen, K.W., Yang, H.L., Lu, J., Wang, G.L., Ji, Y.M., Wu, G.Z., Zhu, L.F., Liu, J.Y., Chen, X.Q., Gu, Y.P. J. Neurooncol. (2010)
- Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas. Rahmah, N.N., Sakai, K., Nakayama, J., Hongo, K. Neurosurg. Rev. (2010)
- Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Naka, T., Iwamoto, Y., Shinohara, N., Ushijima, M., Chuman, H., Tsuneyoshi, M. Mod. Pathol. (1997)
- Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies. Weinberger, P.M., Yu, Z., Kowalski, D., Joe, J., Manger, P., Psyrri, A., Sasaki, C.T. Arch. Otolaryngol. Head Neck Surg. (2005)
- Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas. Shalaby, A.A., Presneau, N., Idowu, B.D., Thompson, L., Briggs, T.R., Tirabosco, R., Diss, T.C., Flanagan, A.M. Mod. Pathol. (2009)
- Overexpressions of nerve growth factor and its tropomyosin-related kinase A receptor on chordoma cells. Park, J.B., Lee, C.K., Koh, J.S., Lee, J.K., Park, E.Y., Riew, K.D. Spine. (Phila. Pa. 1976). (2007)
- Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma. Naka, T., Boltze, C., Samii, A., Samii, M., Herold, C., Ostertag, H., Iwamoto, Y., Oda, Y., Tsuneyoshi, M., Kuester, D., Roessner, A. Histopathology. (2009)
- Expression of hepatocyte growth factor and c-MET in skull base chordoma. Naka, T., Kuester, D., Boltze, C., Scheil-Bertram, S., Samii, A., Herold, C., Ostertag, H., Krueger, S., Roessner, A. Cancer. (2008)
- Gain of chromosome 7 by chromogenic in situ hybridization (CISH) in chordomas is correlated to c-MET expression. Walter, B.A., Begnami, M., Valera, V.A., Santi, M., Rushing, E.J., Quezado, M. J. Neurooncol. (2010)
- Epidermal growth factor receptor (EGFR) status in chordoma. Ptaszyński, K., Szumera-Ciećkiewicz, A., Owczarek, J., Mrozkowiak, A., Pekul, M., Barańska, J., Rutkowski, P. Pol. J. Pathol. (2009)
- MET overexpressing chordomas frequently exhibit polysomy of chromosome 7 but no MET activation through sarcoma-specific gene fusions. Grabellus, F., Konik, M.J., Worm, K., Sheu, S.Y., van de Nes, J.A., Bauer, S., Paulus, W., Egensperger, R., Schmid, K.W. Tumour. Biol. (2010)
- Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas. Tamborini, E., Virdis, E., Negri, T., Orsenigo, M., Brich, S., Conca, E., Gronchi, A., Stacchiotti, S., Manenti, G., Casali, P.G., Pierotti, M.A., Pilotti, S. Neuro. Oncol. (2010)
- The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas. Horbinski, C., Oakley, G.J., Cieply, K., Mantha, G.S., Nikiforova, M.N., Dacic, S., Seethala, R.R. Arch. Pathol. Lab. Med. (2010)
- Molecular analysis of chordomas and identification of therapeutic targets. Shalaby, AAE. Diss. University College London, London. Print. (2010)
WikiGenes . Article - Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. Duan, Z., Choy, E., Nielsen, G.P., Rosenberg, A., Iafrate, J., Yang, C., Schwab, J., Mankin, H., Xavier, R., Hornicek, F.J. J. Orthop. Res. (2010)
- Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization. Yang, H., Zhu, L., Ebraheim, N.A., Liu, X., Castillo, S., Tang, T., Liu, J., Cui, H. Spine. J. (2009)
- The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. Shalaby, A., Presneau, N., Ye, H., Halai, D., Berisha, F., Idowu, B., Leithner, A., Liegl, B., Briggs, T.R., Bacsi, K., Kindblom, L.G., Athanasou, N., Amary, M.F., Hogendoorn, P.C., Tirabosco, R., Flanagan, A.M. J. Pathol. (2011)
- Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway. Presneau, N., Shalaby, A., Idowu, B., Gikas, P., Cannon, S.R., Gout, I., Diss, T., Tirabosco, R., Flanagan, A.M. Br. J. Cancer. (2009)
- The sonic hedgehog pathway in chordoid tumours. Cates, J.M., Itani, D.M., Coffin, C.M., Harfe, B.D. Histopathology. (2010)